Angeles Iglesias-Castro

A Coruna, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.

Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.

Journal: European journal of hospital pharmacy : science and practice

Published: May 18, 2021

Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure.

Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure.

Journal: Journal of viral hepatitis

Published: December 23, 2020

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain.

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain.

Journal: Frontiers in microbiology

Published: May 21, 2020

Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.

Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.

Journal: European journal of hospital pharmacy : science and practice

Published: May 19, 2020

Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice.

Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice.

Journal: Journal of medical virology

Published: December 27, 2019

Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.

Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.

Journal: European journal of hospital pharmacy : science and practice

Published: August 06, 2019

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

Journal: Antiviral research

Published: April 15, 2019

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

Journal: Journal of the International Association of Providers of AIDS Care

Published: February 26, 2019

Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients. Results in real clinical practice.

Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients. Results in real clinical practice.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: February 15, 2019

Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus.

Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus.

Journal: European journal of hospital pharmacy : science and practice

Published: February 05, 2019

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.

Journal: Basic & clinical pharmacology & toxicology

Published: August 03, 2018

Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis.

Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis.

Journal: Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Published: July 24, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026